Louisville, Ky.-based Norton Heart & Vascular Institute performed Kentucky’s first transcatheter tricuspid valve replacement using the Evoque system.
The catheter-based procedure, developed by Edwards Lifesciences, treats severe tricuspid regurgitation and offers a less invasive alternative to open-heart surgery. The Evoque valve is the first transcatheter therapy approved by the FDA for this condition, according to a Dec. 11 Norton Healthcare news release.
The procedure reduces symptoms and improves recovery time. Two successful implantations were completed Dec. 9, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.